Search
for
Sort by
Research 451–480 of 457
- The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss
- Nanotechnology-based techniques for hair follicle regeneration
- Acne Necrotica in Its Entirety: When It Starts, and After It Evolves
- Alopecias: Practical Tips for the Management of Biopsies and Main Diagnostic Clues for General Pathologists and Dermatopathologists
- Folliculitis decalvans: a case report of satisfactory recovery after implementing isotretinoin therapy
- Acne Vulgaris
- Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- When bugs and drugs conspire: driving acneiform skin toxicity
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Incidence and management of cutaneous toxicities associated with cetuximab
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Dermatologic Reactions to Targeted Therapy
- Management of Dermatologic Toxicities
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Prophylaxis and Management of Skin Toxicities
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis